Biswal B M, Bal C S, Sandhu M S, Padhy A K, Rath G K
Department of Radiation Oncology (IRCH), All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
J Neurooncol. 1994;22(1):77-81. doi: 10.1007/BF01058357.
Brain metastases in differentiated carcinoma of the thyroid is a rare occurrence. We treated five documented cases of carcinoma of thyroid with brain metastases out of 400 cases of thyroid cancer treated between 1972 to 1993. 4 were females out of which one was pregnant during the appearance of brain metastases. All cases were treated with thyroidectomy, and radioiodine as primary therapy. Brain metastases developed 6 months to 11 years following treatment of the primary and were treated with radiotherapy and suppressive levothyroxine. We observed the beneficial effect of suppressive thyroxine and the poor prognosis associated with pregnancy and withdrawal of thyroid replacement therapy. 3 of the 5 patients are alive 12-23 months after treatment for brain metastases, while 2 patients died at 4 months and 7 years post brain metastases due to pulmonary and hepatic failure, respectively.
分化型甲状腺癌发生脑转移较为罕见。在1972年至1993年间治疗的400例甲状腺癌患者中,我们记录到5例发生脑转移的甲状腺癌病例。其中4例为女性,1例在出现脑转移时处于妊娠期。所有病例均接受甲状腺切除术及放射性碘作为初始治疗。脑转移在原发癌治疗后6个月至11年出现,采用放射治疗及左甲状腺素抑制治疗。我们观察到左甲状腺素抑制治疗的有益效果,以及与妊娠和停用甲状腺替代治疗相关的不良预后。5例患者中有3例在脑转移治疗后12至23个月存活,而另外2例患者分别在脑转移后4个月和7年因肺衰竭和肝衰竭死亡。